TO THE EDITOR Sjö gren-Larsson syndrome (SLS: OMIM No. 270200) is an autosomal-recessive hereditary disorder characterized by congenital ichthyosis, mental retardation, and spastic diplegia or tetraplegia (Rizzo, 1993) . Rizzo et al. (1988) revealed that long-chain fatty alcohol was abnormally accumulated in cultured fibroblasts, white blood cells and serum in SLS patients. In 1996 , De Laurenzi et al. (1996 reported that mutations in the fatty aldehyde dehydrogenase (FALDH) gene (ALDH3A2) underlie SLS. In the present study, we report novel compound heterozygous mutations in ALDH3A2 in a Japanese family with SLS.
A 2-year-old Japanese girl was suffering from congenital ichthyosis, mental retardation, spastic tetraplegia, and recurrent epileptic seizures. The patient was the first child of nonconsanguineous, healthy Japanese parents. Ichthyosis was not seen in any other family members. She was born as a pre-term baby at 34 weeks 3 days of gestation (body weight, 2392 g), but not a collodion baby. Physical examination revealed fine scales and slight erythema over her whole body ( Figure 1 ). Hyperkeratosis was also seen on the palms and soles. Her hair, nails, and teeth were normal. The skin manifestations were consistent with non-bullous congenital ichthyosiform erythroderma. Her extremities were hypertonic. T2weighted magnetic resonance imaging demonstrated a high-intensity area in her brain periventricular white matter. Ophthalmologic examination revealed retinal crystals, generally referred to as ''glistening white dots''.
To elucidate the precise genetic abnormality in the family, mutational analysis was performed in the affected girl and her parents. Briefly, genomic DNA isolated from peripheral blood cells was subjected to PCR amplification, followed by direct automated sequencing using an ABI PRISM 3100 genetic analyzer (ABI Advanced Biotechnologies, Columbia, MD). Oligonucleotide primers and PCR conditions used for amplification of all exons and exon-intron borders of ALDH3A2 were originally derived from the report by Rizzo et al. (1999) and were partially modified for our study (Shibaki et al., 2004) . The entire coding region including the intron/exon boundaries for both forward and reverse DNA strands from the patient, her parents and 100 healthy Japanese controls were sequenced. In the patient, a combination of two novel heterozygous mutations, 332G4A in exon 2 and 636T4G in exon 4, were identified (Figure 2a ). The mutation 332G4A was present in her father, and the mutation 636T4G was demonstrated in her mother. The presence of both mutations was excluded in 200 alleles of 100 normal unrelated Japanese individuals. The medical ethical committee of the Hokkaido University approved all described studies. These studies were conducted according to the Declaration of Helsinki Principles. The patient's parents gave their written informed consent.
The paternal mutation 332G4A in exon 2 leads to an alteration of the tryptophan residue at codon 111 into a stop codon (nonsense mutation W111X) and this premature translation termination eliminates approximately 80% of the length of FALDH polypeptide (loss of 77.3% length of the FALDH major splice variant). Thus, this nonsense mutation is expected to seriously abolish FALDH function.
The maternal mutation 636T4G in exon 4 resulted in an alteration of a serine at codon 212 to arginine (S212R). FALDH amino-acid sequence alignment shows that this serine residue at codon 212 is conserved among several diverse species (reference sequences: CR457422, XP 511337, NP 113919, CAI25890, NP 001016537, AAK49120) ( Figure 2b ).
In highly conserved among many of the ALDH family members, and participates in one of the 10 most conserved sequence motifs in ALDHs (Figure 2c ). In addition, analysis of the crystallized three-dimensional structure of the related class 3 rat cytosolic ALDH revealed that this serine is located adjacent to the first b-strand, b6, of the six parallels of b-strands, comprising a significant portion of the catalytic domain of the molecule (Liu et al., 1997) ( Figure 2c ). These findings strongly suggest that the serine at codon 212 is important for connecting the a/b structure of a dinucleotide-binding Rossmann fold (Freshney et al., 1994) to the catalytic domain and/or for structural folding of the catalytic domain, and is therefore essential for the normal function of the FALDH protein.
The fact that the present patient harboring the missense mutation S212R showed typical SLS phenotypic features strongly suggests that this serine residue is essential for FALDH enzymatic function. FALDH is a microsomal NADdependent enzyme, which is necessary for the oxidation of long-chain aliphatic aldehydes into fatty acids (Kelson et al., 1997) . The FALDH gene (ALDH3A2) located on chromosome 17p11.2 (De Laurenzi et al., 1996) comprises 11 exons, and is widely expressed in a variety of tissues (Chang and Yoshida, 1997; Rogers et al., 1997) . Until now, a number of mutations in ALDH3A2 have been shown to be responsible for SLS over the world (Rizzo et al., 1999) . Founder effects were observed in certain areas and races (Rizzo et al., 1999; Kraus et al., 2000; Rizzo and Carney, 2005) . In Japanese patients with SLS, one homozygous mutation 1157A4G (N386S) in ALDH3A2 was reported in a patient of one family (Aoki et al., 2000) and two other mutations, 481delA and 1087_1089delGTA, were reported in another family (Shibaki et al., 2004) . We have detected two additional mutations, 332G4A (W111X) and 636T4G (S212R), in the present family. All the mutations detected in Japanese families were distinct one another and we therefore speculate there is no founder effect in Japanese cases with ALDH3A2 mutations causing SLS.
The pathogenesis of the ichthyosis in SLS includes abnormal lamellar or membranous inclusions in cornified cells, which were reported in a patient with SLS, although causative genetic abnormalities were not known in that particular case (Ito et al., 1991) . The inclusions were speculated to be lamellar granule-in-origin. Later, a deficiency in acyl-ceramides in the lipid layer in the stratum corneum was also reported in SLS patients (Paige et al., 1994) . In a previous report (Shibaki et al., 2004) , we observed ultrastructurally abnormal lamellar granules lacking normal lamellar contents in the upper spinous and granular layers. In addition, we showed some malformed lamellar granule components were secreted into the intercellular space in the stratum corneum (Shibaki et al., 2004) . These observations suggest defective lamellar granule formation in SLS. SLS is thought to be a form of ichthyoses caused by defective . ALDH3A2 mutations in the present SLS patient and sequence alignments around the missense mutation. (a) Sequence analysis of the ALDH3A2. A combination of heterozygous mutations derived from their mother (332G4A (W111X) in exon 2) and father (636T4G (S212R) were detected. (b) FALDH amino-acid sequence alignment shows the level of conservation in diverse species of the amino-acid S212 (red characters), which was altered by the missense mutation in the present family. (c) A sequence alignment between the FALDH, rat class 3 and human class 1 and class 2 ALDHs showing the relative locations of key residues in these enzymes. Serine residue at codon 212 of FALDH is strictly conserved. Secondary structure components found in the class 3 rat ALDH structure are presented with a bar and arrows. The bar represents an a-helix and arrows represent b-strands. (Modified from the paper by Liu et al., (1997).) lipid barrier in the stratum corneum (Akiyama, 2006) . As illustrated here, mutation analysis of the ALDH3A2 gene is a highly sensitive method to confirm a diagnosis of SLS, which does not require a skin biopsy and can complement or replace FALDH enzymatic assays or analysis in SLS.
